Press Releases

Repertoire Immune Medicines Strengthens Executive Team; Names Biotech Industry Veterans to Key Roles
CAMBRIDGE, Mass. – April 23, 2020 – Repertoire Immune Medicines, a clinical-stage biotech company working to unleash the curative power of the immune system, today announced the addition of three new members to its executive team: Andrea DiFabio, EVP, Chief Legal and Corporate Administration Officer; Tim Harris, Ph.D., Dsc., EVP, Corporate Development and Lucia Celona, EVP, Chief Human Resources Officer.
Download
Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund
CAMBRIDGE AND BOSTON, MA – March 25, 2020 – Repertoire Immune Medicines, a newly launched company working to unleash the curative power of the immune system to prevent and cure disease, today announced an investment from the JDRF T1D Fund, a venture philanthropy vehicle focused on accelerating life-changing solutions to cure, prevent and treat type 1 diabetes (T1D).
Download
Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer
Cambridge, MA, March 12, 2020 – Flagship Pioneering, a life sciences innovation enterprise, announced the launch of Repertoire Immune Medicines, a clinical-stage biotechnology company tapping the curative powers of our immune system to prevent, treat and cure cancer, autoimmune disorders and infectious diseases.
Download